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Schnurri (Shn) is a large zinc finger protein implicated in cell growth, signal transduction, 
and lymphocyte development. Vertebrates possess at least three Shn orthologues (Shn-1, 
Shn-2, and Shn-3), which appear to act within the bone morphogenetic protein, 
transforming growth factor 
 
 
 
, and activin signaling pathways. However, the physiological 
functions of the Shn proteins remain largely unknown. In 
 
Shn-2
 
–deficient mice, mature 
peripheral T cells exhibited normal anti–T cell receptor–induced proliferation, although 
there was dramatic enhancement in the differentiation into T helper type (Th)2 cells and a 
marginal effect on Th1 cell differentiation. Shn-2–deficient developing Th2 cells showed 
constitutive activation of nuclear factor 
 
 
 
B (NF-
 
 
 
B) and enhanced GATA3 induction. Shn-2 
was able to compete with p50 NF-
 
 
 
B for binding to a consensus NF-
 
 
 
B motif and inhibit 
NF-
 
 
 
B–driven promoter activity. Thus, Shn-2 plays a crucial role in the control of Th2 cell 
differentiation by regulating NF-
 
 
 
B function.
 
CD4 T cell–dependent immune responses are
controlled by the balance of antigen-specific
Th1 and Th2 cells (1–3). IL-12–induced activa-
tion of STAT4 is crucial for Th1 cell differenti-
ation, whereas IL-4–induced STAT6 activation
is crucial for Th2 cell differentiation (4–8). In
addition to cytokine-induced signals, the acti-
vation of the TCR-mediated signaling is indis-
pensable for both Th1 and Th2 cell differenti-
ation. In particular, Th2 cell differentiation is
largely dependent on the activation of p56
 
lck
 
,
calcineurin, and the Ras-ERK MAPK signal-
ing cascade (9–11). A negative regulator of the
above signaling pathways, SHP-1, also controls
the efficiency of Th2 cell differentiation and
Th2 cell–dependent immune responses (12).
Master transcription factors for Th1 and Th2
cell differentiation have been revealed, i.e.,
GATA3 for Th2 cells and T-bet for Th1 cells
(13–17).
In 
 
Drosophila
 
, Mad-Medea and Schnurri
(Shn), a large zinc finger protein, are reported
to interact with each other and act as nuclear
targets in the 
 
Drosophila
 
 decapentaplegic sig-
naling pathway (18–20). In vertebrates, the
 
Drosophila
 
 decapentaplegic signaling pathway
may equate to the bone morphogenetic protein/
TGF-
 
 
 
/activin signaling pathways that play
diverse roles in developmental processes (21).
Vertebrates have at least three orthologues of
Shn: Shn-1 (also known as HIV-EP1, MBP-1,
PRDII-BF1, and 
 
 
 
A-CRYBP1), Shn-2 (also
known as HIV-EP2, MBP-2, AGIE-BP1, and
MIBP1), and Shn-3 (also known as HIV-EP3,
KRC, and ZAS3). The mRNA expression of
Shn-2 was detected mostly in the brain, heart,
and spleen (22–24). Recently, the requirement
of Shn-2 in positive selection of thymocytes
was reported (25) and 
 
Shn-3
 
–deficient CD4
 
 
 
CD8
 
  
 
thymocytes were shown to exhibit a
defect in cell survival (26). However, the pre-
cise physiological roles of these Shn family
members remain largely unknown.
NF-
 
 
 
B is a critical transcription factor
that regulates Th2 cell differentiation and Th2
cell–dependent airway inflammation (27–29).
NF-
 
 
 
B–deficient (p50 subunit–deficient) mice
were unable to mount OVA-induced airway
inflammation (28). The lack of inflammation
was not due to defects in T cell priming, T cell
proliferation, or expression of important cell
adhesion molecules, but rather to the impaired
induction of GATA3 (30). Recently, one of
the Shn family members, Shn-3 (KRC), was
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reported to associate with TNF receptor–associated factor
(TRAF)2 to repress nuclear translocation of NF-
 
 
 
B (31). In
addition, Shn-3 (ZAS3) was shown to bind to the NF-
 
 
 
B
motif directly, and the competition with NF-
 
 
 
B binding re-
sulted in the repression of transactivation of the NF-
 
 
 
B tar-
get gene (32, 33). A direct repressive activity of Shn-3 was
Figure 1. Enhanced Th2 cell differentiation in Shn-2 /    DO11.10 
TCR Tg T cells. (A) Naive (CD44low) CD4 T cells from Shn-2 /    DO11.10 
Tg mice were purified by cell sorting and stimulated with antigenic OVA 
peptide (Loh15: 0.1  M) and irradiated BALB/c APCs for 5 d. Th2 cell–skewed 
(IL-4 with anti–IL-12 mAb and anti–IFN-  mAb), Th1 cell–skewed (IL-12 
with anti–IL-4 mAb), and nonskewed (IL-2 with anti–IL-4 mAb, anti–IL-12 
mAb, and anti–IFN-  mAb) conditions were used. Intracellular staining was 
performed with FITC-conjugated anti–IFN-  mAb and PE-conjugated anti–
IL-4 mAb. Under the typical Th2 cell–skewed conditions, the levels of Th2 
cell differentiation in five experiments were 17.5   2.9% in Shn-2 /  cul-
tures and 38.0   11.8% in Shn-2 /  cultures. P   0.006. (B) A portion of 
the same differentiated cell cultures used in A were restimulated with anti-
genic peptide and APCs for 24 h, and the concentrations of cytokines (IL-4, 
IL-5, and IFN- ) in the culture supernatant were determined by ELISA. 
(C) Naive (CD44low) CD4 T cells from Shn-2 /    DO11.10 Tg mice were 
stimulated with a specific OVA peptide (Loh15: 0.1  M) and irradiated nor-
mal BALB/c APCs in the presence of indicated doses of IL-4. Intracellular 
staining profiles of IFN-  and IL-4 are shown with percentages of cells in 
each area. (D) Purified naive (CD44low) CD4 T cells were stimulated with indi-
cated doses of specific OVA peptides (Loh15: 0.3 and 1.0  M) and irradiated 
BALB/c APCs in the presence or absence of 30 U/ml of exogenous IL-2. Two 
independent experiments were performed with similar results. 
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also demonstrated (33). These emerging findings suggest that
the Shn protein is involved in NF-
 
 
 
B activation and/or NF-
 
 
 
B–mediated gene transactivation.
Here, we investigate the role of Shn-2 in Th1/Th2 cell
differentiation by using Shn-2–deficient (
 
Shn-2
 
 
 
/
 
 
 
) mice.
Our results suggest that Shn-2 plays crucial roles in the con-
trol of Th2 cell differentiation by regulating NF-
 
 
 
B activa-
tion and GATA3 expression.
 
RESULTS
Phenotypic and functional characterization of peripheral 
CD4 T cells in 
 
Shn-2
 
–deficient (
 
Shn-2
 
   
 
) mice
 
Shn-2
 
 
 
/
 
  
 
mice were previously shown to have a defect in T
cell generation due to the impairment of positive thymic se-
lection (25). However, we found that moderate numbers
of CD4 and CD8 T cells were present in 
 
Shn-2
 
 
 
/
 
  
 
mice
of a BALB/c background (Fig. S1 A, available at http://
www.jem.org/cgi/content/full/jem.20040733/DC1). The
cell surface expression of TCR-
 
 
 
, CD3
 
 
 
, common 
 
  
 
(
 
 
 
C),
IL-4R
 
 
 
, CD25, CD69, CD44, and CD62L on splenic CD4
T cells was found to be comparable to those of controls (Fig.
S1 B). The TCR V
 
  
 
chain repertoire in the peripheral 
 
Shn-
2
 
 
 
/
 
 
 
 
 
T cells was similar to that of 
 
Shn-2
 
 
 
/
 
  
 
T cells (Fig. S1
C). Anti–TCR-
 
 
 
– or anti-CD3
 
 
 
–induced proliferative re-
sponses were the same in 
 
Shn-2
 
 
 
/
 
 
 
 
 
and 
 
Shn-2
 
 
 
/
 
 
 
 
 
CD4 T
cells (Fig. S2 A). Furthermore, the phosphorylation status of
MAPKs (Erk1 and Erk2) after TCR cross-linking in 
 
Shn-2
 
 
 
/
 
 
 
CD4 T cells was comparable to that of controls (Fig. S2 B).
Thus, no obvious defect in the phenotype or the activation
of 
 
Shn-2
 
 
 
/
 
  
 
splenic CD4 T cells was noted. The expression
of Shn-2 mRNA was detected in freshly prepared CD4 T
cells, and it was decreased after anti-TCR stimulation in
Th1 and Th2 cell differentiation cultures (Fig. S3).
 
Enhanced Th2 cell differentiation in 
 
Shn-2
 
 
 
/
 
  
 
  
 
DO11.10 
transgenic (Tg) naive CD4 T cells
 
Next, we assessed the capability of 
 
Shn-2
 
 
 
/
 
  
 
CD4 T cells to
differentiate into Th1/Th2 cells. Naive splenic CD4 T cells
(CD4
 
  
 
CD44
 
low
 
) were purified by cell sorting (purity
 
 
 
98%) and then subjected to in vitro Th1/Th2 cell differ-
entiation culture and analyzed by intracellular cytokine
staining and ELISA. Naive CD4 T cells from 
 
Shn-2
 
 
 
/
 
  
 
 
 
OVA–specific TCR-
 
   
 
Tg (DO11.10 Tg) mice were stim-
ulated with 0.1 
 
 
 
M of antigenic OVA peptide and irradi-
ated BALB/c splenocytes in the presence of appropriate
cytokines and anti-cytokine mAbs under three different
conditions: Th2-skewed (IL-4 with anti–IL-12 mAb and
anti–IFN-
 
  
 
mAb), Th1-skewed (IL-12 with anti–IL-4
mAb), and nonskewed (IL-2 with anti–IL-4 mAb, anti–IL-
12 mAb, and anti–IFN-
 
 
 
 mAb) conditions. As shown in
Fig. 1 A, Th2 cell differentiation was enhanced substantially
in 
 
Shn-2
 
 
 
/
 
  
 
T cells (17.3 vs. 37.1%), whereas Th1 cell dif-
ferentiation was unaffected (83.0 vs. 80.5%). Under non-
skewed conditions, the baseline levels of IL-4–producing
and IFN- –producing cells were increased in Shn-2 /  T
cell cultures (Fig. 1 A, left). Portions of the same cell cul-
tures that were used for intracellular cytokine staining were
restimulated, and cytokine production was measured by
ELISA. Basically, a similar pattern among cultures was ob-
served (Fig. 1 B). The production of IL-4 and IL-5 was in-
creased about twofold in Shn-2 /  Th2 cells, whereas simi-
lar levels of IFN-  production in Th1 cells were detected.
The levels of IL-4 and IFN-  production in nonskewed
cultures were very low, but they were slightly increased in
the Shn-2 /  cultures.
To examine further the effect on Th2 cell differentiation,
naive CD4 T cells from Shn-2 /     DO11.10 Tg mice
were stimulated with a minimum dose of antigenic peptide
(0.1  M) and APCs in the presence of graded doses of exog-
enous IL-4. As shown in Fig. 1 C, IL-4–producing Th2 cells
were generated in an exogenous IL-4 dose-dependent man-
ner in wild-type Shn-2 /  T cell cultures. As expected, the
generation of Th2 cells in Shn-2 /  mice was dramatically
enhanced at all doses of exogenous IL-4. The number of IL-
5–producing cells was also enhanced in Shn-2 /  T cell cul-
tures (not depicted). Also, we detected increased numbers of
IFN- –producing cells at all groups. Next, we examined the
effect of the concentration of antigenic peptide and IL-2 in
the culture. Naive CD4 T cells purified by cell sorting were
stimulated with two different doses of antigenic peptide (0.3
or 1.0  M) and irradiated APCs from normal BALB/c mice
in the absence of exogenous IL-4. A dramatic increase in the
numbers of IL-4–producing Th2 cells was observed in Shn-
2 /  cultures at either dose of antigenic peptide (Fig. 1 D,
left). In the presence of exogenous IL-2, Th2 cell generation
was enhanced in both Shn-2 /  and Shn-2 /  T cell cultures,
although the levels were substantially higher in Shn-2 / 
groups as compared with Shn-2 / .
Enhanced Th2 cell differentiation in Shn-2 /  splenic CD4 
T cells after anti-TCR mAb stimulation
To further assess the efficiency of Th2 cell differentiation in
the splenic Shn-2 /  T cells, purified splenic naive CD4 T
cells (purity  98%) were stimulated with immobilized anti–
TCR-  mAb in the presence of graded doses of exogenous
IL-4. No APCs were added. 30 U/ml of exogenous IL-2
was added to the differentiation cultures. As shown in Fig. 2
A, IL-4–producing Th2 cells were generated in an exoge-
nous IL-4 dose-dependent manner in the Shn-2 /  wild-
type T cell cultures, and as expected, the generation of Th2
cells in Shn-2 /  mice was substantially enhanced in the cul-
tures at all doses of exogenous IL-4 (Fig. 2 A). These results
suggest that the ability to differentiate into Th2 cells was en-
hanced in Shn-2 /  splenic CD4 T cells. The number of
Th2 cells generated in Shn-2 /    STAT6 /  T cell cul-
tures was insignificant, suggesting that the enhanced Th2 cell
differentiation in Shn-2 /  T cell cultures was STAT6 de-
pendent (not depicted).
To assess the effect on Th1 cell differentiation in a non-
TCR Tg system, Shn-2 /  splenic CD4 T cells were stimu-
lated with anti–TCR-   mAb in the presence of various
doses of exogenous IL-12 and anti–IL-4 mAb (Fig. 2 B).TH2 CELL DIFFERENTIATION CONTROLLED BY SCHNURRI-2 | Kimura et al. 400
Figure 2. Enhanced Th2 cell differentiation in Shn-2 /  T cells. 
(A) Splenic naive CD4 T cells from Shn-2 /  mice were stimulated with 
immobilized anti–TCR-  mAb, 30 U/ml of exogenous IL-2, and indicated 
concentrations of IL-4 for 5 d. Intracellular staining profiles of IFN-  and 
IL-4 are shown with percentages of cells in each area. The absolute numbers 
of cells harvested in these cultures were similar. Three independent experi-
ments were performed with similar results. (B) Splenic naive CD4 T cells 
from Shn-2 /  mice were stimulated with immobilized anti–TCR-  mAb in 
the presence of indicated doses of IL-12 and anti–IL-4 mAb. Intracellular 
staining profiles of IFN-  and IL-4 are shown with percentages of cells in 
each area. The absolute numbers of cells harvested in these cultures were 
similar. Three independent experiments were performed with similar results. 
(C) Splenic naive CD4 T cells were labeled with CFSE and stimulated with 
immobilized anti–TCR-  mAb in the presence of IL-4 and IL-2. After cultur-
ing for the indicated times, cells were restimulated and subjected to intra-
cellular staining with APC-conjugated anti–IL-4 mAb. Percentages of the 
cells in the gates representing numbers of cell division (0–7) and percent-
ages of IL-4–producing Th2 cells in each gate are shown in the right panels. 
Percentages of IL-4–producing cells in total (without gating) are 0.7% 
(24 h), 5.4% (48 h), 28.6% (72 h), and 29.3% (96 h) in Shn-2 /  cultures 
and 0.6% (24 h), 5.4% (48 h), 36.9% (72 h), and 37.9% (96 h) in Shn-2 /  
cells. Two independent experiments were performed with similar results.JEM VOL. 201, February 7, 2005 401
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Moderate increases in the generation of Th1 cells were ob-
served in groups with no exogenous IL-12 or a low dose of
IL-12 (1 U/ml). However, no further increases but rather a
slight decrease in the number of Th1 cells generated was ob-
served at higher doses of IL-12 (10 or 100 U/ml). A similar
pattern was obtained in STAT6-deficient Th1 cell cultures
(not depicted). We observed similar enhancement in the
generation of Th2 cells in Shn-2 /  mice with either a B6
background or a B6   BALB/c background (not depicted).
Anti-TCR–induced cell division of Shn-2 /  CD4 T cells
Because some cycles of cell divisions are reported to be re-
quired for the generation of IL-4–producing Th2 cells (34),
we examined the anti-TCR–induced cell division of Shn-
2 /  CD4 T cells. Carboxyfluorescein diacetate succinimidyl
ester (CFSE)-labeled naive CD4 T cells were stimulated
with anti–TCR-  mAb in the presence of IL-2 and IL-4
(Th2 cell–skewed condition), and 24, 48, 72, and 96 h later,
IL-4 production in the developing Th2 cells was assessed
(Fig. 2 C). 24 h after the stimulation, most cells had not un-
dergone cell division (cell division no. 0), and IL-4–produc-
ing Th2 cells were not detected. At 48 h, cells had under-
gone up to three cell divisions, and there was a slight
increase in the numbers of cells with three cell divisions de-
tected in Shn-2 /  CD4 T cells. The percentages of IL-4–
producing T cells generated were not apparently different
between Shn-2 /  and Shn-2 /  CD4 T cell cultures at this
time point. After 72 and 96 h in culture, the rate of cell divi-
sion appeared to be slightly increased in Shn-2 /  CD4 T
cells, and the generation of IL-4–producing T cells was
higher at all numbers of cell division. These results suggest
that although Shn-2 /  CD4 T cells show a slightly in-
creased rate in cell division, the enhanced Th2 cell genera-
tion in Shn-2 /  CD4 T cells could not be simply explained
by the difference in the number of cell divisions that the de-
veloping Th2 cells had undergone.
We reported previously that CD28 costimulation in-
duced increased Th2 cell differentiation (35) and induced
NF- B activation and enhanced GATA3 expression in de-
veloping Th2 cells to facilitate chromatin remodeling of the
IL-5 gene loci (36). Shn-2 /  T cells were stimulated with
anti-TCR plus anti-CD28 mAb under Th2 cell–skewed
conditions (Fig. S4, available at http://www.jem.org/cgi/
content/full/jem.20040733/DC1). Shn-2 /  T cells showed
increased levels of Th2 cell differentiation without anti-
CD28 mAb as compared with wild-type (46.2 vs. 32.4%).
No obvious additional enhancement of Th2 cell differentia-
tion was detected in the presence of CD28 costimulation
under the conditions where the CD28-mediated enhancing
effect was observed in Shn-2 /  T cell cultures.
Figure 3. The function of Shn-2 /  APCs. (A) OVA-pulsed immature 
or mature BMDCs were cocultured with DO11.10 Tg CD4 T cells for 72 h. 
[3H]thymidine (37 kBq/well) was added to the stimulation culture for the 
last 16 h. The results (mean and standard deviation) of [3H]thymidine in-
corporation are shown. Three independent experiments were performed 
with similar results. (B) OVA-pulsed immature or mature BMDCs (2   104 
cells) were cocultured with DO11.10 Tg naive (CD44low) CD4 T cells (2   105 
cells) under nonskewed, Th2 cell–skewed, and Th1 cell–skewed conditions 
for 5 d. Intracellular staining profiles (IFN- /IL-4) of the cultured cells are 
shown with percentages of the cells in each quadrant. Three independent 
experiments were performed with similar results. (C) Naive (CD44low) CD4 T 
cells (1.5   104 cells) were purified from Shn-2 /    DO11.10 Tg mice by 
cell sorting and stimulated with indicated doses of specific OVA peptides 
(Loh15: 0.1  M) and irradiated CD4  spleen cells (105 cells) from non-
DO11.10 Tg Shn-2 /  or Shn-2 /  mice. Two independent experiments 
were performed with similar results.TH2 CELL DIFFERENTIATION CONTROLLED BY SCHNURRI-2 | Kimura et al. 402
No functional defect was observed in DCs 
from Shn-2 /  mice
The results thus far suggested that the observed enhancement
of Th2 cell differentiation is due to an alteration in T cells
because we used purified T cells (Figs. 1 and 2) and APCs
from normal mice (Fig. 1). However, Shn-2 mRNA is ex-
pressed in both CD4 T cells and APCs (not depicted), and
thus, we wished to evaluate the effect of Shn-2 deficiency on
APC function using bone marrow–derived DCs (BMDCs).
The expression levels of CD11c, I-Ad, H-2Kd, CD40, B7-1,
B7-2, and Fas were comparable between Shn-2 /  and Shn-
2 /  BMDCs (not depicted). OVA-pulsed BMDCs from
Shn-2 /  or Shn-2 /  mice were cocultured with DO11.10
Tg CD4 T cells, and proliferative responses of T cells were
assessed by [3H]thymidine uptake. Under these conditions,
the APC function of both immature and mature BMDCs
was found to be comparable between Shn-2 /  or Shn-2 / 
mice (Fig. 3 A). We then examined the ability of OVA-
pulsed BMDCs as APCs to induce Th1/Th2 cell differentia-
tion. Stimulation with either immature or mature BMDCs
resulted in similar levels of Th1/Th2 cell differentiation in
the cultures with Shn-2 /  and Shn-2 /  BMDCs (Fig. 3 B).
To further evaluate the APC function of Shn-2 /  mice,
spleen cells were irradiated and tested for their ability to in-
duce Th1/Th2 cells. The numbers of Th2 cells generated
were found to be comparable between cultures with Shn-2 / 
and  Shn-2 /  APCs (Fig. 3 C). Taken together, the en-
hanced Th2 cell generation in Shn-2 /  T cell cultures ap-
pears to be due to an alteration in CD4 T cells themselves
and not to any change in APC function.
Hyperactivation of NF- B in Shn-2 /  CD4 T cells
We examined the NF- B activation in Shn-2 /  CD4 T cells
by electrophoretic mobility shift assays (EMSAs). CD4 T cells
from Shn-2 /  and Shn-2 /  mice were stimulated with anti-
TCR and anti-CD28 for 3 h, and subsequently, nuclear ex-
tracts were prepared. To facilitate the stimulation of the TCR
complex on naive T cells, we used both anti-TCR and anti-
CD28 mAbs. The NF- B DNA binding activity was found
to be increased after TCR stimulation in Shn-2 /  CD4 T
cells (Fig. 4 A, lanes 2 and 3, and B, lanes 2 and 14). In con-
trast, in Shn-2 /  CD4 T cells, substantial levels of binding
activity could already be detected even in nonstimulated T
cells (Fig. 4 A, lane 4, and B, lanes 7 and 17), and an only
Figure 4. Hyperactivation of NF- B in Shn-2 /  CD4 T cells. 
(A and B) Splenic CD4 T cells were incubated with medium alone overnight 
and then stimulated with immobilized anti–TCR-   mAb in the presence 
or absence of agonistic anti-CD28 antibody for 3 h. Nuclear extracts of the 
cultured cells were prepared and subjected to EMSAs with NF- B probes. 
The supershift assays were performed with antibodies specific for NF- B 
p50 and p65 subunit detection. Three independent experiments were per-
formed with similar results. (C) Splenic CD4 T cells were incubated with 
medium alone overnight and then stimulated with immobilized anti–TCR-  
mAb for 3 h. Subsequently, both cytosol and nuclear extracts were pre-
pared and these were subjected to immunoblotting using anti-p50, anti-p65, 
anti–tubulin- , and anti–histone H1 antibodies. Arbitrary densitometric 
units are shown under each band. (D) RNAs were prepared from fresh 
splenic CD4 T cells, resting CD4 T cells that were incubated with medium 
alone overnight, and anti-TCR–stimulated CD4 T cells, and then quantita-
tive PCR assay was performed. The expression levels of p50 and p65 were 
normalized with 18S expression. Two independent experiments were per-
formed with similar results.JEM VOL. 201, February 7, 2005 403
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moderate elevation in activity was observed after TCR stim-
ulation (Fig. 4 A, lanes 5 and 6, and B, lanes 8 and 18). We
performed a supershift assay to determine the specificity for
NF- B subunits and observed a substantial supershift with the
anti-p65 antibody (Fig. 4 A, lanes 8 and 9, and B, lanes 4 and
15). A small, but reproducible shift was detected in Shn-2 / 
nonstimulated samples (Fig. 4 A, lane 10, and B, lane 9). In-
creased amounts of p65 supershift band were detected after
anti-TCR stimulation in Shn-2 /  T cells. Furthermore, an
EMSA with anti-p50 antibody revealed that most of the NF-
 B EMSA band detected in nonstimulated Shn-2 /  T cells
contained the p50 subunit (Fig. 4 B, lane 11). There was a
substantial increase in the level of the p50 band after anti-
TCR stimulation (Fig. 4 B, lane 12). These results suggest
that NF- B is constitutively activated in Shn-2 /  CD4 T
cells and it is hyperactivated after anti-TCR stimulation. We
did not observe any obvious disappearance of specific bands
in  Shn-2    groups. This could be due to an insufficient
amount of Shn-2 for visualization in the EMSA assay.
An assessment of the protein expression levels of NF- B
p50 and p65 subunits in the cytosol and in nuclear fractions
revealed that no obvious difference was detected between
Shn-2 /  and  Shn-2 /  T cells before or after anti-TCR
stimulation, suggesting that the nuclear translocation of the
NF- B p50 and p65 subunits is not altered in the absence of
Shn-2 (Fig. 4 C). Furthermore, transcriptional levels of p50
and p65 were compared by quantitative RT-PCR assay us-
ing freshly prepared CD4 T cells, resting CD4 T cells, and
those after anti-TCR stimulation for 3 h (Fig. 4 D). In all
cases, basically no difference was detected between Shn-2 / 
and Shn-2 /  groups.
We also examined the activation of AP-1, CREB, and IL-4
NFAT in Shn-2 /  CD4 T cells by EMSA (Fig. S5, avail-
able at http://www.jem.org/cgi/content/full/jem.20040733/
DC1). The DNA binding ability of AP-1 was slightly, but re-
producibly, enhanced in Shn-2 /  T cells, whereas the DNA
binding activity of CREB and IL-4 NFAT appeared to be
similar in Shn-2 /  and Shn-2 /  T cells.
Enhanced expression of GATA3 in anti-TCR–activated 
Shn-2 /  CD4 T cells
Because the levels of GATA3 expression are critical for Th2
cell differentiation (14) and because GATA3 expression is
regulated by NF- B (30), we next assessed the protein ex-
pression of GATA3 in cultured Shn-2 /  T cells under Th2
cell–skewed condition. Splenic CD4 T cells from Shn-2 / 
mice were stimulated with anti–TCR-  mAb and IL-4, and
16 h later, the expression of GATA3 was assessed by immu-
noblotting with specific antibodies. The levels of GATA3
protein were found to be reproducibly increased in Shn-2 / 
T cells (Fig. 5 A). No detectable GATA3 protein was ob-
served in freshly prepared Shn-2 /  CD4 T cells (not de-
picted). Concurrently, the mRNA levels were assessed by
semiquantitative RT-PCR analysis, and increased GATA3
mRNA levels were detected (Fig. 5 B). These results suggest
that enhanced induction of GATA3 takes place in early de-
veloping Shn-2 /  Th2 cells as compared with that of con-
trol Shn-2 /  Th2 cells.
Figure 5. Increased GATA3 expression in Shn-2 /  developing Th2 
cells. (A) Splenic CD4 T cells were cultured under Th2 cell–skewed conditions 
for 16 h. The cells were lysed, and cell lysates with threefold serial dilutions 
of cell lysates were subjected to immunoblotting using anti-GATA3 or 
anti–tubulin-  antibodies. Arbitrary densitometric units are shown under 
each band. (B) Splenic CD4 T cells were cultured under Th2 cell–skewed 
conditions for 6 h, and the expression levels of GATA3 mRNA were deter-
mined by RT-PCR. Arbitrary densitometric units are shown under each 
band. (C) Expression of NFAT1 and NFAT2 in Shn-2 /  Th2 cells. Splenic 
CD4 T cells were stimulated under Th2 cell–skewed conditions for 2 or 5 d, 
and then both cytosol and nuclear cell lysates were prepared. Immuno-
blotting was performed with anti-NFAT1 or anti-NFAT2 antibodies. Arbi-
trary densitometric units are shown under each band. (D) Splenic CD4 T 
cells were cultured under Th1 cell–skewed conditions for 6 or 16 h, and 
the expression levels of T-bet mRNA were determined by quantitative PCR 
assay. The expression was normalized with 18S expression. Two indepen-
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We examined the cytosolic or nuclear protein expression
levels of NFAT1 and NFAT2 in developing Th2 cells (Fig. 5
C). In either cytosolic or nuclear lysate, there was no clear
difference in the expression of NFAT1 detected between
Shn-2 /  and  Shn-2 /  T cells, suggesting normal nuclear
translocation of NFAT1 occurs. The nuclear translocation of
NFAT2 was, however, slightly impaired in Shn-2 /  T cells.
An assessment of the expression of other molecules that may
regulate Th2 cell differentiation directly or indirectly, such as
JunB, cMaf, Bcl-6, and TRAF2, revealed no clear difference
in mRNA expression levels in Shn-2 /  developing Th2 cells
(not depicted). In addition, mRNA levels of several NF- B
target genes (IL-6, IL-1 , IL-15, and IL-17) are increased in
Shn-2–deficient T cells (not depicted). The levels of T-bet in
the  Shn-2 /  and  Shn-2 /  cells cultured under Th1 cell–
skewed conditions are shown in Fig. 5 D. No significant dif-
ference was observed in the levels of T-bet mRNA.
Shn-2 inhibits an NF- B–dependent transcriptional activity
The ability of Shn-2 protein to bind to the consensus NF- B
binding motif was assessed. 293 T cells were transfected with
a pAct-Flag-hShn-2 vector, and 2 d later, nuclear extracts
were prepared. Biotinylated NF- B and control AP-1 oligo-
nucleotides were absorbed on to streptavidin-agarose beads
and incubated with the nuclear extracts. The amount of Shn-2
protein in the precipitates of agarose beads was assessed by
immunoblotting with anti-Flag mAb. Total nuclear extracts
were also run in parallel as loading controls. As can be seen in
Fig. 6 A, a substantial binding of Flag–Shn-2 protein to NF-
 B oligo was observed. This result suggests that Shn-2 protein
is able to bind to a consensus NF- B binding motif.
Next, we wished to examine whether Shn2 competes ef-
fectively with p50 NF- B for binding to a consensus NF- B
binding motif. Nuclear extracts were prepared from 293 T
cells that were transfected with pAct-Flag-hShn2 or pCMX-
p50 vectors. The extracts were mixed in specific ratios and
then incubated with NF- B oligonucleotides absorbed with
streptavidin-agarose beads. The bound protein was detected
by immunoblotting with an anti-Flag mAb for Shn-2 and an
anti-p50 mAb for p50 protein. As shown in Fig. 6 B, left,
the binding of p50 to NF- B oligonucleotides was inhibited
by Shn-2–containing extracts in a dose-dependent manner.
In addition, the binding of Shn-2 to NF- B oligonucle-
otides was inhibited by the presence of p50 (Fig. 6 B, right).
These results clearly suggest that Shn-2 competes with p50
for binding to a consensus NF- B motif.
Consequently, to determine whether Shn-2 protein plays
a functional role in NF- B–dependent transcription, NF-
Figure 6. Inhibition of NF- B–dependent transcriptional activity 
by Shn-2. (A) 293 T cells were transfected with a control pAct or a pAct-
Flag-hShn-2 vector, and 2 d later, their cell lysates were prepared. Biotin-
ylated NF- B and control AP-1 oligonucleotides were absorbed by 
streptavidin-agarose beads, and then the beads were incubated with cell 
lysates. The amount of Shn-2 protein in the precipitates was assessed by 
immunoblotting with anti-Flag mAb. Total cell lysates (106 equivalent/
lane) were also run as controls (input). Three independent experiments were 
performed with similar results. (B) Nuclear extracts were prepared from 
293 T cells transfected with pAct-Flag-hShn2 or pCMX-p50 vectors. The 
extracts were mixed in a certain ratio and then incubated with NF- B oli-
gonucleotides absorbed with streptavidin-agarose beads. The numbers 
represent the volume of cell lysates ( l; 1  l   5   105 cell equivalent). 
none, nontransfected 293 T lysates. The bound protein was detected by 
immunoblotting with an anti-Flag mAb for Shn-2 and an anti-p50 mAb 
for p50 protein. Total cell lysates were also run as controls (input). The po-
sition of Shn-2 and p50 are indicated. Three experiments were performed 
with similar results. (C) 293 T cells were transfected with 25 ng of the 5  NF-
 B reporter constructs with the indicated doses of a pAct control vector 
(Mock) or a pAct-Flag-hShn-2 vector (Shn-2). Additionally, 1 ng pRL-TK 
vector was added into each transfection as an internal control. 24 h after 
the transfection, cells were stimulated with 50 ng/ml PMA and 500 nM 
ionomycin or 10 ng/ml TNF-  for12 h and then assayed for luciferase
activity.JEM VOL. 201, February 7, 2005 405
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 B–induced luciferase assay was performed with 293 T cells
transfected with the 5   NF- B reporter constructs along
with graded doses of pAct-Flag-hShn-2 vector after stimula-
tion with PMA plus ionomycin or TNF-  (Fig. 6 C). Some
level of luciferase activity was detected without stimulation,
and a significant inhibition was observed in the presence of
Shn-2. After PMA plus ionomycin stimulation, the luciferase
activity was increased and this was efficiently inhibited by
Shn-2 (Fig. 6 C, middle). The luciferase activity was in-
creased dramatically by stimulation with TNF- , and this was
moderately inhibited in the presence of Shn-2 protein (Fig. 6
C, right). These results suggest that Shn-2 protein is able to
inhibit the NF- B–dependent transcriptional activity.
DISCUSSION
In this report, we demonstrated a crucial role for Shn-2 in
Th2 cell differentiation. Shn-2 appears to control NF- B
DNA binding activity and subsequent GATA3 induction in
early developing Th2 cells.
The DNA binding of NF- B was enhanced in Shn-2–
deficient CD4 T cells (Fig. 4, A and B). The enhancement
was already apparent in nonstimulated Shn-2–deficient CD4
T cells. However, we found the NF- B protein equally ex-
pressed in the nucleus and cytoplasm of nonstimulated and
stimulated Shn-2–deficient CD4 T cells (Fig. 4 C). Thus, the
enhanced DNA binding of NF- B might be regulated by
nuclear events such as those involved in the DNA binding
process. A previous report suggested that Shn-3 binds to a
NF- B motif and represses transactivation of NF- B–depen-
dent genes (33). We show here that Shn-2 protein is able to
bind to a consensus NF- B motif (Fig. 6 A) and compete
with p50 for DNA binding in a dose-dependent manner
(Fig. 6 B). In addition, we detected significant inhibition of
the NF- B–dependent transcriptional activity in 293 T cells.
Thus, it is conceivable that Shn-2 is able to bind to NF- B
DNA binding motifs and thus compete with the binding of
NF- B complexes or to repress directly the transactivation
of the NF- B–dependent genes in early developing Th2
cells. This might be a mechanism to account for the elevated
NF- B DNA binding activity in nonstimulated Shn-2–defi-
cient CD4 T cells (Fig. 4, A and B).
In addition, we detected a further enhancement of DNA
binding of NF- B after TCR stimulation (Fig. 4, A and B).
This could explain the enhanced induction of GATA3 in
early developing Shn-2 /  Th2 cells (Fig. 5, A and B). A sim-
ilar regulation was demonstrated in an experimental system
using p50 /  mice (30). In our preliminary results, the gener-
ation of IL-4–producing Th2 cells in wild-type BALB/c CD4
T cell cultures was increased by the ectopic expression of both
p50 and p65 (unpublished data). Thus, it appears probable
that the enhanced induction of GATA3 by NF- B hyperacti-
vation is a mechanism that is responsible for the enhanced
Th2 cell differentiation observed in Shn-2–deficient T cells.
Another interesting possibility for the molecular targets
of Shn-2 is the involvement of TRAF2-mediated NF- B
activation. A previous report suggested that there is a physi-
cal association of Shn-3 with TRAF2 (31). Our preliminary
results suggest that a physical association of Shn-2 with
TRAF2 in 293 T cells can be demonstrated (unpublished
data). Thus, Shn proteins may bind to TRAF2 and inhibit
the TNFR-induced NF- B activation and nuclear translo-
cation in T cells. However, this appeared to be unlikely be-
cause no obvious difference in the protein expression of p50
and p65 was observed in the cytosol or nucleus before or af-
ter anti-TCR stimulation between Shn-2 /  and Shn-2 / 
T cells (Fig. 4 C). Lieberson et al. (37) have reported
that Th2 cell responses are enhanced in dominant-negative
TRAF2 Tg CD4 T cells. This result would appear to be
contradictory to the above hypothesis. However, the domi-
nant-negative TRAF2 used in the study by Lieberson et al.
inhibits JNK activity efficiently, but it does not affect NF- B
activity very significantly (38). Thus, it is still possible that
the Shn-2–TRAF complex is formed in T cells and that it is
involved in the control of Th2 cell differentiation by regu-
lating NF- B activation. A more precise investigation is
needed to clarify this issue.
As for the signaling pathways in which Shn-2 is in-
volved, Shn-2 may regulate outcomes of both the TCR-
and TNF-dependent pathways if the major function of
Shn-2 is mediated by a mechanism proposed above, namely,
competition with NF- B for DNA binding in the nucleus.
In this paper, we focused our analysis mostly on T cells
where the TNF-dependent signaling pathway is not acti-
vated efficiently, and thus, further investigation will be re-
quired to address this issue. In addition, we did not observe
CD28 costimulation-mediated enhancement of Th2 cell dif-
ferentiation in Shn-2 /  cells (Fig. S4). CD28 costimulation
induced NF- B activation and enhanced GATA3 expression
in developing Th2 cells (36). Thus, it is possible that the ef-
fect of CD28 costimulation was masked by hyperactivation
of NF- B in Shn-2 /  T cells.
It has been established that the expression of GATA3 is
crucial for the efficient Th2 cell differentiation (16). GATA3
plays an essential role in chromatin-remodeling processes,
such as acetylation of histone H3 and H4 of the Th2 cell cy-
tokine gene loci (36). The activation of STAT6 is most crit-
ical for the induction of GATA3 transcription (16, 39).
More recently, several regulatory molecules for GATA3
transcription have emerged. One is the NF- B activation
discussed above (30). We reported previously that a poly-
comb group gene product, mel-18, controls Th2 cell differ-
entiation by regulating GATA3 transcription (40). Shn-2 is
another example of a protein that regulates GATA3 tran-
scription and expression in developing Th2 cells. Further in-
vestigation of the regulation of GATA3 expression is likely
to provide a clearer molecular view of the initiation of Th2
cell differentiation.
Recombinant TGF-  inhibited Th2 cell differentiation
of normal and Shn-2–deficient T cells very efficiently (un-
published data). In addition, Smad7 expression was not
changed in Shn-2–deficient T cells (unpublished data). Thus,
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ing pathway in T cells, at least not in the TGF- –mediated
inhibition of Th2 cell differentiation. However, because
mammalian Shn has three orthologues (Shn-1, Shn-2, and
Shn-3), it is still possible that Shn-1 and/or Shn-3 could sub-
stitute for the function of Shn-2 in Shn-2–deficient T cells.
As for the effects of Shn-2 deficiency on Th1 cell differ-
entiation, Shn-2 may not play critical roles in Th1 cell dif-
ferentiation. No effect was observed in typical Th1 cell–
skewed cultures containing excess amounts of IL-12 (Fig. 1
A). However, we observed some enhancement in Th1 cell
differentiation when IL-12 is limiting (Fig. 2 B). Also, IFN-
 –producing cells generated under Th2 cell–skewed condi-
tions were increased consistently (Fig. 1 C). Thus, it is still
possible that Shn-2 may act as a negative regulator of the
generation of IFN- –producing cells.
In summary, the results of this study indicate that Shn-2
plays crucial roles in the control of Th2 cell differentiation
by regulating the activation of NF- B and subsequent
GATA3 induction in early developing Th2 cells.
MATERIALS AND METHODS
Mice. Shn-2–deficient (Shn-2 / ) mice were described previously (25).
Animals used in this study were backcrossed to BALB/c more than 12 times
and were 6–8 wk old. Anti-OVA–specific TCR-   (DO11.10) Tg mice
were provided by D. Loh (Washington University School of Medicine, St.
Louis, MO; reference 41). Shn-2 /    DO11.10 Tg mice were used at 10–
12 wk of age. STAT6-deficient (STAT6 / ) mice were provided by S.
Akira (Osaka University, Osaka, Japan; reference 39). All mice used in this
study were maintained under specific pathogen-free conditions. Animal
care was in accordance with the guidelines of Chiba University.
Immunofluorescent staining and flow cytometry analysis. In gen-
eral, 106 cells were incubated on ice for 30 min with the appropriate stain-
ing reagents according to a standard method (42). The reagents used in
this study were as follows: anti-CD4–PE (RM4-1–PE), anti-CD4–FITC
(RM4-1–FITC), anti-CD44–FITC (IM7-FITC), anti-CD44–PE (IM7-
PE), anti-CD69–FITC (H1.2F3), anti-CD62L–FITC (MEL-14), anti-
CD25–FITC (7D4), anti–IL-4R  antibody, and anti- C antibody-PE were
purchased from BD Biosciences. Anti–rat Ig-FITC was purchased from
CAPPEL. Anti–TCR- –FITC (H57-FITC), anti-CD3–FITC (2C11-FITC),
and anti-CD8–Cy5 were prepared in our laboratory. Flow cytometry anal-
ysis was performed on a FACSCalibur (Becton Dickinson), and results were
analyzed with CELLQuest software (Becton Dickinson). Intracellular stain-
ing of IL-4 and IFN-  was performed as described previously (11). FITC-
conjugated anti–IFN-   antibody (XMG1.2), APC-conjugated anti–IL-5
antibody, and PE-conjugated anti–IL-4 antibody (11B11; all from BD Bio-
sciences) were used for detection.
Cell purification. Splenic CD4 T cells were purified by using magnetic
beads and an Auto-MACS Sorter (Miltenyi Biotec) yielding a purity of
 98%. Where indicated, CD4 T cells with naive phenotype (CD44low)
were isolated from spleens on a FACSVantage cell sorter (Becton Dickin-
son) yielding a purity of  98% as described previously (11).
Bone marrow DC cultures. A modified method of Inaba et al. (43) and
Chen-Woan et al. (44) was used for bone marrow DC cultures. In brief,
bone marrow cells depleted of FcR  cells (0.5–1.0   106 cells) were cul-
tured in 1 ml medium in the presence of 10 ng/ml GM-CSF. The culture
medium was changed every other day by gently swirling the plates, aspirat-
ing  75% of the medium, and adding back fresh medium with cytokines.
On day 6, the cells were harvested and then CD11c  cells (immature DCs)
were purified using anti-CD11c mAb-conjugated micro beads and a MACS
LS column (Miltenyi Biotec). The purified immature CD11c  DCs were
cultured for an additional 2 d with 10 ng/ml GM-CSF and 1  g/ml LPS to
allow further maturation and were used as mature DCs.
Proliferation assay. 2   105 splenic CD4 T cells were stimulated in 200-
 l cultures for 40 h with immobilized anti–TCR-  mAb (H57-597) and
anti-CD3  mAb (2C11). Immature or mature DCs were pulsed with 1  M
OVA peptide for 2 h at 37 C and then cocultured with CD4 T cells from
DO11.10 Tg mice for 72 h. [3H]thymidine (37 kBq/well) was added to the
stimulation culture for the last 16 h, and the incorporated radioactivity was
measured by using a   plate (40).
ELISA for the measurement of cytokine concentration. The pro-
duction of IL-2, IL-4, IL-5, IL-13, and IFN-  was measured by ELISA as
described previously (40).
In vitro Th1/Th2 cell differentiation cultures. Naive splenic CD4 T
cells were stimulated with 3  g/ml of immobilized anti–TCR-   mAb
(H57-597) in the presence of 30 U/ml IL-2 and 1–100 U/ml IL-4 as de-
scribed previously (10). Where indicated, naive splenic CD4 T cells were
labeled with CFSE (Molecular Probes) using the same procedure as de-
scribed previously (40). For Th1 cell differentiation, naive splenic CD4 T
cells were stimulated with 3  g/ml of immobilized anti–TCR-   mAb
(H57-597) in the presence of 30 U/ml IL-2, IL-12, and anti–IL-4 mAb. 1.5  
104 sorted DO11.10 Tg CD44low CD4 T cells were stimulated with anti-
genic OVA peptide (Loh15, OVA; 323–339) and 105 irradiated (3,000 rad)
normal BALB/c splenocytes. For stimulation with purified DCs, 2   105
sorted DO11.10 Tg CD44low CD4 T cells were cocultured with 2   104
OVA-pulsed immature or mature DCs. Appropriate cytokines and anti-
cytokine antibodies were added in Th1/Th2 cell differentiation cultures as
described previously (11). In typical DO11.10 Tg T cell cultures, Th2 cell–
skewed (IL-4 with anti–IL-12 mAb and anti–IFN-   mAb), Th1 cell–
skewed (IL-12 with anti–IL-4 mAb), and nonskewed (IL-2 with anti–IL-4
mAb, anti–IL-12 mAb, and anti–IFN-  mAb) conditions were used.
Immunoblotting. The Immunoblotting for the detection of GATA3, tu-
bulin- , NFAT1, and NFAT2 was performed as described previously (45).
For NF- B detection, anti-p65 (F-6), anti-p50 (E-10), and anti–histone H1
(AE-4, all from Santa Cruz Biotechnology, Inc.) antibodies were used.
EMSA. EMSAs were performed using Gel Shift Assay Systems (Promega)
according to the manufacturer’s instructions. In brief, nuclear extracts were
incubated at 4 C with 32P-labeled double-stranded oligo (NF- B oligo;
AGTTGAGGGGACTTTCCCAGGC, AP-1 oligo; CGCTTGATGAGT-
CAGCCGGAA, CREB oligo; AGAGATTGCCTGACGTCAGAGAG-
CTAG, IL-4 NFAT; oligo; and GTAATAAAATTTTCCAATGTAAA) in
DNA binding buffer (Promega). For supershift assays, nuclear extracts were
incubated with anti-p50 (C-19; Santa Cruz Biotechnology, Inc.) or anti-
p65 (F-6; Santa Cruz Biotechnology, Inc.) antibody at 4 C for 60 min and
then incubated with 32P-labeled NF- B double-stranded oligo at 4 C. Elec-
trophoresis was performed on a 4% native polyacrylamide gel (0.5  TBE;
acrylamide/bisacrylamide, 29:1), and the radioactivity was visualized by
autoradiography.
Pull-down assay. A detailed protocol was described elsewhere (46). In
brief, 293 T cells were transfected with 1.0  g pAct or pAct-Flag-hShn-2,
and 2 d later, the transfected cells were lysed for immunoblotting with anti-
Flag mAb (M2; Sigma-Aldrich). Cell lysates were incubated with biotinyl-
ated oligonucleotides of NF- B (AGTTGAGGGGACTTTCCCAGGC)
and AP-1 (CGCTTGATGAGTCAGCCGGAA). The bound protein were
eluted and separated on an SDS polyacrylamide gel and then subjected to
immunoblot analysis using specific antibodies (anti-Flag Tag; M2; Sigma-
Aldrich). For the competition assay shown in Fig. 6 B, 293 T cells were
transfected with pAct-Flag-hShn-2 or pCMX-p50, and their cell extracts
were mixed in certain ratios and then the mixed extracts were incubatedJEM VOL. 201, February 7, 2005 407
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with NF- B oligonucleotides as described above. pCMX-p50 was provided
by J. Inoue (University of Tokyo, Tokyo, Japan). Anti-Flag Tag (M2;
Sigma-Aldrich) mAb and anti-p50 (E-10; Santa Cruz Biotechnology, Inc.)
mAb were used for detection.
Transfection and luciferase assays. 293 T cells were transfected with
5  NF- B luciferase reporter plasmid together with pAct vector or pAct-
Flag-hShn-2 vector and pRL-TK as normalization control. Transfected
cells were stimulated with or without 50 ng/ml PMA and 500 nM ionomy-
cin or 10 ng/ml TNF-  for 12 h before luciferase assays (Promega).
PCR analysis. Total RNA was isolated from cultured cells using the TR-
Izol reagent. Reverse transcription was performed with Superscript II RT
(Invitrogen). Threefold serial dilutions of template cDNA were performed.
The PCR reaction was performed as described previously (46). The primers
used are as follows:   actin forward, GAGAGGGAAATCGTGCGTGA-3 ;
  actin reverse, 5 -ACATCTGCTGGAAGGTGGAC; GATA3 forward,
gAAggCATCCAgACCCgAAAC-3 ; GATA3 reverse, 5 -ACCCATgg-
CggTgACCATgC; Shn-2 forward, ggAAAgAgggAAAggAgAgATTCA-
CggAgAT-3 ; and Shn-2 reverse, 5 -ATCTgAgTgTCATCACAAgAgT-
CACTgggT.
For quantitative PCR assay, first-strand cDNA was synthesized using
random primers and Superscript II RT (Invitrogen). Samples were then
subjected to real-time PCR analysis on an ABI PRISM 7000 Sequence De-
tection System (Applied Biosystems) under standard conditions. The prim-
ers and TaqMan probes for the detection of p50, p65, T-bet, and 18S were
purchased from Applied Biosystems. p50, p65, and T-bet expression were
normalized using the 18S signal.
Online supplemental material. Fig. S1 shows the phenotypic feature of
splenic CD4 T cells from Shn-2 /  mice. (A) The yields of thymocytes and
splenocytes are shown in boxed numbers. (B) Each histogram depicts the
expression of the indicated marker antigens on electronically gated splenic
CD4 T cells. Background staining is shown as hatched areas. (C) The histo-
gram shows the percentages of indicated V  cells among splenic CD4 T
cells. Fig. S2 shows the proliferative responses and Erk phosphorylation sta-
tus after TCR stimulation. Arbitrary densitometric units are shown under
each band in B. Fig. S3 shows the expression of Shn-2 mRNA in develop-
ing Th1 and Th2 cells. The mRNA levels were determined by RT-PCR
with threefold serial dilutions of template cDNA. Fig. S4 shows the effects
of CD28 stimulation on Th2 cell differentiation. Gel shift assay for AP-1,
CREB, or IL-4 NFAT are shown in Fig. S5. Figs. S1–S5 are available at
http://www.jem.org/cgi/content/full/jem.20040733/DC1.
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